Terra Metals Limited (ASX:TM1) Expands Dante Project with HRM Acquisition
Terra Metals (ASX:TM1) acquires HRM Exploration Pty Ltd, nearly doubling its Dante Project holdings in Western Australia.
Category: Companies
Nanoveu Limited (ASX:NVU) Participates in Pitt Street Research Semiconductor Conference 2025
Nanoveu Limited (ASX:NVU) announces participation in Pitt Street Research Semiconductor Conference 2025, showcasing advanced semiconductor and AI technologies.
Lunnon Metals (ASX:LM8) Announces First Mineral Resource Estimate for Lady Herial
Lunnon Metals (ASX:LM8) reports its first Mineral Resource Estimate for the Lady Herial gold deposit, outlining significant resource details and plans for rapid commercialization.
TechGen Metals Limited (ASX:TG1) Extends High Grade Gold Anomaly at John Bull Project
TechGen Metals (ASX:TG1) extends high grade gold anomaly at John Bull Project ahead of drilling preparations.
EcoGraf Limited (ASX:EGR) Secures Second HFfree® Purification Patent
EcoGraf Limited (ASX:EGR) secures a second HFfree® purification patent, enhancing its battery anode material technology and sustainable recycling efforts.
First Graphene Limited (ASX:FGR) Announces Multi-Year Safety Boot Deal
First Graphene (ASX:FGR) secures exclusive multi-year deal to supply graphene-enhanced safety boots for the Southeast Asia mining sector.
Contact Energy Limited (ASX:CEN) Receives Commerce Commission Clearance for Manawa Acquisition
Contact Energy Limited (ASX:CEN) receives Commerce Commission approval for its acquisition of Manawa Energy, advancing the NZ energy transition.
JB Hi-Fi Limited (ASX:JBH) Reports Sales Growth
JB Hi-Fi Limited (ASX:JBH) reports continued sales growth in Q3 FY25, with strong performance in Australia and New Zealand.
Zip Co Limited (ASX:ZIP) Releases April 2025 Trading Update
Zip Co Limited (ASX:ZIP) releases April 2025 trading update, showcasing record cash EBTDA and robust US market growth.
CLINUVEL (ASX:CUV) Completes Phase III Vitiligo Trial Recruitment
CLINUVEL (ASX:CUV) completes recruitment for its Phase III vitiligo trial, with initial results expected in the second half of 2026.